DE69635987D1 - Verbesserte liposomale formulierung - Google Patents

Verbesserte liposomale formulierung

Info

Publication number
DE69635987D1
DE69635987D1 DE69635987T DE69635987T DE69635987D1 DE 69635987 D1 DE69635987 D1 DE 69635987D1 DE 69635987 T DE69635987 T DE 69635987T DE 69635987 T DE69635987 T DE 69635987T DE 69635987 D1 DE69635987 D1 DE 69635987D1
Authority
DE
Germany
Prior art keywords
liposomal formulation
improved liposomal
instability
improved
alum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635987T
Other languages
English (en)
Other versions
DE69635987T2 (de
Inventor
R Alving
Jean M Muderhwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JENNER TECHNOLOGIES DANVILLE
Original Assignee
JENNER TECHNOLOGIES DANVILLE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JENNER TECHNOLOGIES DANVILLE filed Critical JENNER TECHNOLOGIES DANVILLE
Application granted granted Critical
Publication of DE69635987D1 publication Critical patent/DE69635987D1/de
Publication of DE69635987T2 publication Critical patent/DE69635987T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
DE69635987T 1995-06-07 1996-06-06 Verbesserte liposomale formulierung Expired - Fee Related DE69635987T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US480563 1995-06-07
US08/480,563 US5820880A (en) 1995-06-07 1995-06-07 Liposomal formulation
PCT/US1996/009432 WO1996040065A1 (en) 1995-06-07 1996-06-06 Improved liposomal formulation

Publications (2)

Publication Number Publication Date
DE69635987D1 true DE69635987D1 (de) 2006-05-18
DE69635987T2 DE69635987T2 (de) 2006-11-16

Family

ID=23908444

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635987T Expired - Fee Related DE69635987T2 (de) 1995-06-07 1996-06-06 Verbesserte liposomale formulierung

Country Status (9)

Country Link
US (1) US5820880A (de)
EP (1) EP0831780B1 (de)
JP (1) JPH11507628A (de)
AT (1) ATE321534T1 (de)
AU (1) AU721085B2 (de)
CA (1) CA2221310A1 (de)
DE (1) DE69635987T2 (de)
ES (1) ES2262155T3 (de)
WO (1) WO1996040065A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
ATE430199T1 (de) 1998-01-31 2009-05-15 Univ Arkansas Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
WO2000071711A2 (en) * 1999-05-20 2000-11-30 Fahri Saatcioglu Differentially expressed genes in prostate cancer
JP2004521602A (ja) * 2000-03-24 2004-07-22 ファハリ サッチオグリュ 前立腺特異的または精巣特異的な新規の核酸分子、ポリペプチド、ならびに診断法および治療法
US7189565B2 (en) * 2001-03-23 2007-03-13 Fahri Saatcioglu Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US7611892B2 (en) * 2000-03-24 2009-11-03 President And Fellows Of Harvard College Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
JP2004527450A (ja) * 2000-04-06 2004-09-09 シーア ファーマスーティカルズ エルエルシー 微生物送達システム
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
JP3990880B2 (ja) * 2001-07-10 2007-10-17 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソームの製造方法
US7914801B1 (en) 2002-03-21 2011-03-29 The United States Of America As Represented By The Secretary Of Agriculture Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations
US7279163B1 (en) 2002-03-21 2007-10-09 The United States Of America, As Represented By The Secretary Of Agriculture Water-in-oil emulsion vaccines
AU2003296335A1 (en) * 2002-12-06 2004-06-30 Board Of Regents, The University Of Texas System Compositions and methods related to lipid:emodin formulations
CA2515391A1 (en) * 2003-02-12 2004-08-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier
JP5554496B2 (ja) * 2005-09-19 2014-07-23 ニューロナセント インコーポレイテッド 神経発生を刺激するための、およびニューロン変性を阻害するための方法および組成物
DK2170340T3 (en) 2007-06-21 2016-03-14 Neuronascent Inc Methods and compositions for Stimulating neurogenesis and inhibition of neuronal degeneration BY USING ISOTHIAZOLOPYRIMIDINONER
WO2009133867A1 (ja) * 2008-05-01 2009-11-05 片山化学工業株式会社 金属コロイド含有リポソーム
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
WO2015054662A1 (en) 2013-10-10 2015-04-16 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
WO2023056368A1 (en) 2021-09-30 2023-04-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
WO2023140901A1 (en) 2022-01-21 2023-07-27 Elanco Us Inc. Molidustat formulations and methods of use for treatment of anemia in cats

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
KR900701304A (ko) * 1988-05-05 1990-12-01 루이즈 츄이 콜린스 에이미 사람 및/또는 동물용 알레르겐 탈감작제
AU654824B2 (en) * 1990-06-29 1994-11-24 Chiron Corporation Vaccine compositions containing liposomes
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
US5585103A (en) * 1991-07-25 1996-12-17 Idec Pharmaceutical Corporation Induction of cytotoxic T-lymphocyte responses
ZA941645B (en) * 1994-03-09 1995-01-13 South To South Co Operation In Antibodies specifically reactive against human prostate specific antigen.

Also Published As

Publication number Publication date
WO1996040065A1 (en) 1996-12-19
AU6099796A (en) 1996-12-30
DE69635987T2 (de) 2006-11-16
ATE321534T1 (de) 2006-04-15
JPH11507628A (ja) 1999-07-06
US5820880A (en) 1998-10-13
EP0831780B1 (de) 2006-03-29
EP0831780A4 (de) 1999-05-19
CA2221310A1 (en) 1996-12-19
AU721085B2 (en) 2000-06-22
EP0831780A1 (de) 1998-04-01
ES2262155T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
DE69635987D1 (de) Verbesserte liposomale formulierung
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
ATE198143T1 (de) Zahnpasten
BG104247A (en) Resorcinol derivatives
IT1275955B1 (it) Formulazioni farmaceutiche in forma di gel tissotropico
DK0825847T3 (da) Tandrensningspræparater
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
DE69612496T2 (de) Siliziumdioxid-schleifmittel
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
TR28023A (tr) Yüzeyaktif iyon cifti floresanli beyazlatici terkipleri.
TR199800415T1 (en) Farmas�tik form�lasyon.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
HUP0001970A2 (hu) Gombaellenes szert és foszfolipidet tartalmazó készítmények
ITBO970640A0 (it) Apparecchio per l'elettroemanazione di principi attivi.
ATE201988T1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4- benzochinon
DK0625899T3 (da) Liposom-itraconazolformuleringer
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
ATE120718T1 (de) Herstellung von peroxidzusammensetzungen.
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
ES2082515T3 (es) Composiciones de aseo.
DE69431662T2 (de) Stabilisierte tablettenformulierung
ES2090170T3 (es) Agente de recubrimiento espermicida.
ITTO910815A0 (it) Preparazione enzimatica solida esente da tensioattivi,contenente pro teasi come enzima attivo
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee